Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

[DDL 12-00 006]. Stangl, N. Luangkhot, J. Jauernig, D. Häuser, F.-C. Lintz, R. Liening- Ewert, D. Jahn, M. Keller, M. Knoch: Estimating the Efficiency of a Vibrating Membrane Nebuliser. DDL XI, London, December 11-12, 2000; Proceedings, pp. 207 - 210, (poster presentation).
[DDL 12-00 005] Luangkhot, J. Jauernig, A. Balcke, F.-C. Lintz, R. Liening-Ewert, R. Stangl, M. Keller: Characterisation of salbutamol solution compared to budesonide suspensions consisting of submicron and micrometer particles in the PARI LC STAR® and a new PARI electronic Nebuliser (e-Flow). DDL XI, London, December 11-12, 2000; Proceedings, pp. 14 - 17, (oral presentation). M. Knoch, E. Sommer: Jet Nebulizer Design and Function. Eur Respir Rev 2000; 10: 72, 183-186.
[AAPS 10-00 004] N. Luangkhot, J. Jauernig, A. Balcke, D. Jahn, R. Liening-Ewert, R. Stangl, F.-C. Lintz, M. Keller, M. Knoch: Characterisation of salbutamol solution compared to budesonide suspensions consisting of submicron- and micrometer particles in the PARI LC STAR® and a PARI Electronic Nebuliser (e-Flow) Prototype. AAPS Annual Meeting, Indianapolis, Oct. 29 - Nov. 2, 2000, (poster presentation), No. 2117.
[RDD 05-00 003] R. Stangl, N. Luangkhot, R. Liening-Ewert, D. Jahn: Characterising the First Prototype of a Vibrating Membrane Nebuliser. RDD VII, Palm Harbor at Tarpon Springs (Florida), May 14-18, 2000; Proceedings pp. 455 - 458, (poster presentation).
[RDD 05-00 002] W. H. DeHaan, E. Sommer: The potential of infrared sensors for online aerosol characterization. RDD VII, Palm Harbor at Tarpon Springs (Florida), May 14 - 18, 2000. Proceedings pp. 561 - 563.
T. Todisco, A. Eslami, S. Baglioni, T. Sposini, C. Tascini, E. Sommer, M. Knoch: Basis for Nebulized Antibiotics: Droplet Characterization and In Vitro Antimicrobial Activity Versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Journal of Aerosol Medicine 13 (1), 2000, pp. 11-16.
C. Winnips, M. Keller: The role of pMDIs in pulmonary drug delivery. Innovations in Pharmaceutical Technology 6, 2000, pp 70-75.
R. Stangl, N. Luangkhot, R. Liening-Ewert, D. Jahn: Charakterisierung des Funktionsmodells eines neuartigen Verneblers. In: G. Scheuch (Hrsg.): Aerosole in der Inhalationstherapie IV. München-Deisenhofen 2000. Dustri-Verlag Dr. Karl Feistle. S. 96 – 97.
N. Luangkhot, D. Jahn, E. Sommer, M. Knoch: Reduzierung der Behandlungsdauer und des Füllvolumens in der Verneblertherapie unter Verwendung einer unverdünnten Salbutamol-Lösung. In: G. Scheuch (Hrsg.): Aerosole in der Inhalationstherapie IV. München-Deisenhofen 2000. Dustri-Verlag Dr. Karl Feistle. S. 98 – 103.